Repeated attempts at molecular stratification of DCIS have been inconclusive3,4, leaving open the question of whether there are cell-autonomous processes that restrain ERBB2-amplified premalignancies within the duct. Here, ERBB2 is linked to ductal breast carcinoma in situ.